Drawing for REVERSE - DISEASE RX

USPTO serial 99117473

REVERSE - DISEASE RX

Status 688Notice of Allowance
Filing date
Apr 2, 2025
Status date
Feb 17, 2026
Registration date
Examiner
DWYER, JOHN D

Need help with REVERSE - DISEASE RX?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Owner

  • Ashish Kumar

    Palo Alto, CA, US

  • Ashish Kumar

    Palo Alto, CA, US

Goods and services

ClassDescriptionStatusFirst use
044Health careACTIVEMar 20, 2025

Prosecution history

DateCodeEvent
Aug 2, 2026EISUTEAS STATEMENT OF USE RECEIVED
Feb 17, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025PUBOPUBLISHED FOR OPPOSITION
Dec 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2025XAECEXAMINER'S AMENDMENT ENTERED
Nov 30, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 30, 2025GNEAEXAMINERS AMENDMENT E-MAILED
Nov 30, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 26, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 26, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2025GNRTNON-FINAL ACTION E-MAILED
Sep 3, 2025CNRTNON-FINAL ACTION WRITTEN
Aug 30, 2025DOCKASSIGNED TO EXAMINER
Aug 16, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Apr 2, 2025NWAPNEW APPLICATION ENTERED

Related guidance